Press Releases Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
10.85 ^USD	-5.57%		-24.44%	+19.23%

Apr. 17	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 16	Oppenheimer Upgrades Avalo Therapeutics to Outperform From Perform, Price Target is $35	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors	Apr. 02	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	Apr. 01	AQ
Avalo Reports 2023 Financial Results and Provides Business Updates	Mar. 29	AQ
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million	Mar. 27	AQ
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split	Dec. 27	AQ
Avalo Therapeutics : 2023 Annual Meeting of Stockholders	Dec. 18	PU
Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split	Dec. 07	AQ
Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates	Nov. 09	AQ
Avalo Completes Divestiture of AVTX-800 Series	23-10-31	AQ
Catheter Precision Inc. (NYSE American: VTAK) Nasdaq/NYSE Stocks Ignite Multiple Buzzers (AVTX, SPCB, INTZ)	23-10-11	AQ
Kaival Brands Innovation Group, Inc. (NASDAQ: KAVL) Global Expansion Generates Revenues w/Philip Morris (NYSE: PM): LIFW, AVTX, NVOS	23-09-29	AQ
BestGrowthStocks.com Issues a Comprehensive Analysis of Avalo Therapeutics	23-09-27	AQ
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation	23-09-26	AQ
Nano-Cap Medical Watchlist (TBRIF, CLRB, AVTX, SISI)	23-09-25	AQ
Avalo Enters into Agreement to Divest AVTX-800 Series	23-09-12	AQ
Avalo Therapeutics : H.C. Wainwright Conference Presentation	23-09-06	PU
Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference	23-09-06	AQ
Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates	23-08-03	AQ
Avalo Therapeutics : July 2023 Investor Presentation	23-07-21	PU
Avalo to Participate in SVB Securities Therapeutics Forum	23-07-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Press Releases

Filters